X
IMGN

Xponance’s Immunogen Inc IMGN Stock Holding History

Xponance’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,492
Closed -$430K – 1332
2023
Q4 		$430K Buy
14,492
+328
+2% +$6.53K 0.01% 982
2023
Q3 		$225K Sell
14,164
-128
-0.9% -$2.13K ﹤0.01% 1098
2023
Q2 		$270K Buy
14,292
+2,027
+17% +$23.9K ﹤0.01% 1073
2023
Q1 		$47.1K Hold
12,265
– – ﹤0.01% 1194
2022
Q4 		$60.8K Buy
12,265
+185
+2% +$1K ﹤0.01% 1177
2022
Q3 		$58K Buy
12,080
+486
+4% +$2.56K ﹤0.01% 1142
2022
Q2 		$52K Buy
11,594
+1,378
+13% +$5.99K ﹤0.01% 1155
2022
Q1 		$49K Buy
+10,216
New +$56.6K ﹤0.01% 1145
2021
Q3 		– Sell
-10,494
Closed -$69K – 1245
2021
Q2 		$69K Buy
+10,494
New +$73.2K ﹤0.01% 1225

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Xponance's IMGN Position: Q1 2024 in Review

Xponance sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 14,492 shares — an estimated $430K sold.

Xponance first reported a position in IMGN in Q2 2021 and held it in 9 quarters. The position peaked at $430K in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Xponance reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Xponance sold 14,492 Immunogen Inc shares in Q1 2024, an estimated $430K.
  • Xponance first reported a position in Immunogen Inc in Q2 2021 and held it in 9 quarters.
  • Xponance's Immunogen Inc position peaked at $430K in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Xponance's 13F filing for Q1 2024, filed 13 May 2024.